Tessera Grants CEO Oster 1M Options at $1.15 Strike

# Tessera Grants CEO Oster 1M Options at $1.15 Strike

Tessera Defense and Homeland Security Inc. (NYSE American: HLSQ) announced on Oct. 7, 2026 that it and its wholly owned Israeli subsidiary entered an employment agreement with Chief Executive Officer Michael Oster. The package includes options on up to 1,000,000 shares at a $1.15 exercise price, 1,000,000 restricted stock units vesting over three years, and 400,000 fully vested shares. A separate performance tranche pays out only if EBITDA per share clears $0.05 in fiscal 2027.

Context — why Tessera tied its CEO pay to EBITDA per share

The agreement is the first compensation structure Tessera has disclosed since Oster became CEO on March 4, 2026. It formalizes a role he had already been performing through a period the company describes as a fundamental transformation.

Director Reuven Yeganeh said Oster "has led Tessera through a fundamental transformation," citing the move out of biotechnology into defense and homeland security technology and the completed acquisitions of Zorronet and DFSL. The company said the agreement reflects the Board's confidence in his leadership and aligns a meaningful portion of his pay with stockholder interests through EBITDA-per-share performance.

What changed to trigger the agreement now is a shareholder vote. The equity awards are conditioned on stockholders approving an increase in shares available under the company's 2026 Equity Incentive Plan at a Special Meeting on October 20, 2026. Tessera said it filed a definitive proxy statement for that meeting and will file a supplement describing the awards.

A second catalyst sits alongside the vote. The company disclosed it has raised more than $6 million in net proceeds through its at-the-market offering program at an average net price of approximately $1.15 per share, as adjusted for a one-for-ten reverse stock split. An existing financing source also agreed to increase available resources by $5 million through a line of credit.

Those two figures explain why the strike price matters. The option exercise price of $1.15 sits at the same level as the average net price the company reported for its at-the-market sales, so the award is priced where existing capital was raised rather than at a discount to it.

Data — the numbers inside Oster's pay package

The equity component breaks into three pieces. The option covers up to 1,000,000 shares at $1.15. The restricted stock units total 1,000,000 and vest over three years. The fully vested grant is 400,000 shares, issued in recognition of service since March 2026.

The performance tranche is tiered. For fiscal 2027, Oster receives 200,000 shares if EBITDA per share exceeds $0.05, plus an additional 100,000 shares for each full cent above that level, capped at 500,000 shares. For fiscal 2028, the identical structure applies above a $0.10 threshold, also capped at 500,000 shares.

The company defined its terms precisely. EBITDA means earnings before net financing expenses, income taxes, depreciation and amortization. EBITDA per share means EBITDA divided by the weighted average number of shares outstanding used to calculate basic earnings per share, in each case from audited consolidated financial statements prepared under U.S. GAAP.

Tessera flagged that EBITDA and EBITDA per share are not measures calculated in accordance with U.S. GAAP. It also said all awards, including the fully vested shares, remain subject to required corporate approvals and NYSE American approval of the listing of the underlying shares.

Here is the before-and-after on the performance gate: fiscal 2027 requires EBITDA per share above $0.05 to open the award, while fiscal 2028 requires above $0.10 — double the threshold one year later, with the same 500,000-share ceiling on both.

Analysis — what the award signals about Tessera's capital structure

The share-count implications are the part that reaches beyond compensation. Every tranche is settled in stock, so the maximum issuance across the option, the restricted units, the vested grant and both performance years is substantial relative to a company that just completed a one-for-ten reverse split. The reverse split itself indicates the share count was previously high enough that the company chose to consolidate it.

The EBITDA-per-share denominator is the mechanism worth watching. Because the metric divides EBITDA by weighted average basic shares, issuing more shares raises the bar Oster must clear to earn the next tranche. That structure creates a partial internal check on dilution: the CEO's own payout becomes harder to reach as the share count grows.

The counter-argument is straightforward. EBITDA strips out financing expenses, taxes, depreciation and amortization, and Tessera's own disclosure lists a going concern qualification and a NYSE American continued listing compliance process among its risk factors. A metric that excludes financing costs can look healthier than the cash position underneath it, and the report does not disclose the company's current EBITDA or EBITDA per share.

Positioning here is narrow. HLSQ is a small-cap NYSE American listing with no index membership disclosed, so the marginal flow is retail and specialist rather than institutional. The $5 million line of credit and the at-the-market proceeds are the funding side; the equity plan amendment is the dilution side, and both converge on the October 20 vote.

Outlook — what to watch next

The Special Meeting of Stockholders on October 20, 2026 is the first hard date. Stockholder approval of the increase in shares available under the 2026 Equity Incentive Plan is a condition for the awards, and the company said it will file a supplement to its definitive proxy statement describing them.

Fiscal 2027 is the second checkpoint. The $0.05 EBITDA-per-share threshold determines whether the first 200,000-share tranche is earned, and the company said there can be no assurance it will achieve any particular level of EBITDA or EBITDA per share.

A third item is the NYSE American listing approval for the underlying shares, which the company listed as a required corporate approval alongside the stockholder vote. Tessera also referenced a compliance plan period for continued listing standards without stating whether it has regained compliance.

The report names no support or resistance levels and no moving averages, so there are no chart levels to cite. The only price reference it gives is the $1.15 option strike and the approximately $1.15 average net price on the at-the-market sales.

Frequently Asked Questions

What does the Tessera CEO pay package mean for HLSQ shareholders?

Every award is settled in company stock, so approval of the equity plan amendment increases the potential share count. The 400,000 vested shares, 1,000,000 restricted units and up to 1,000,000 option shares all draw on the plan. The EBITDA-per-share gate ties part of the payout to a metric the company must actually hit, which the Board said aligns the CEO with stockholders.

What happens if Tessera misses the $0.05 EBITDA per share target for 2027?

The company said there can be no assurance it will achieve any particular level of EBITDA or EBITDA per share, or that any performance-based award will be earned or issued. If fiscal 2027 EBITDA per share does not exceed $0.05, the 200,000-share tranche and the 100,000-share increments above it are not earned. The fiscal 2028 award has its own separate $0.10 threshold.

Why did Tessera set the option exercise price at $1.15?

The company did not explain the choice. The figure matches the approximately $1.15 average net price per share, as adjusted for the one-for-ten reverse split, that Tessera reported for more than $6 million in net proceeds raised through its at-the-market offering program. That places the strike where the company most recently raised equity capital.

Bottom Line

Tessera has priced its CEO's equity at the level it just sold stock, with future payouts gated on EBITDA per share thresholds the company has never disclosed meeting.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.